Anne-Marie Yvon helps our clients develop and execute cost-effective approaches for building, managing, and enforcing U.S. and international patent portfolios. Her biopharma experience includes immunotherapy, recombinant protein therapy, pharmaceutical and veterinary vaccines, gene therapy and gene expression, recombinant cell therapy, stem cell therapy, enzymes and enzymatic assays, immunoassays, and pharmaceutical formulations and dosage forms.
Anne-Marie has nearly two decades of experience in all aspects of patent procurement, from identifying inventions, assessing patentability, and determining inventorship, to preparing patent applications, guiding prosecution strategy, and managing foreign counsel. Her enforcement experience includes representing plaintiffs and defendants in patent infringement litigations, which gives her unique insight into avoiding patent drafting and prosecution decisions that could have negative consequences during an enforcement proceeding. She has also conducted detailed freedom-to-operate, invalidity, non-infringement, and competitive landscape analyses. In addition, she has performed thorough due diligence analyses for collaboration and licensing arrangements, as well as potential mergers/acquisitions of intellectual property assets. Anne-Marie combines this extensive experience with a keen appreciation of the business needs driving many patent procurement and enforcement decisions.
- Grimes & Yvon LLP, 2014-present
- WilmerHale, LLP, 2008-2014
- Frommer Lawrence & Haug, LLP, 2001-2008
- J.D. cum laude, Fordham University School of Law, New York, NY
- Ph.D., University of Massachusetts, Amherst, MA
- B.A., Biology-Chemistry, Skidmore College, Saratoga Springs, NY
- New York
- United States Patent & Trademark Office